Aytu Biopharma (AYTU) Gross Margin (2014 - 2026)
Aytu Biopharma's Gross Margin was 64.63% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 3.12 percentage points from 67.75% a year earlier but up 3.40 percentage points from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Gross Margin (2014 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Gross Margin at Aytu Biopharma came in at 63.95%, down 5.09 percentage points from FY2025.
- Gross Margin shows a five-year change of +19.46 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Gross Margin was 69.04% in FY2025 (-6.21 pp), 75.26% in FY2024 (+13.21 pp), 62.04% in FY2023 (+7.96 pp) and 54.08% in FY2022 (+9.59 pp).
- Quarterly Gross Margin has moved between 52.42% (fiscal Q3 2022) and 77.89% (fiscal Q2 2024) over five years.
- Compared with a year earlier, Gross Margin has declined for eight straight quarters, with an average year-over-year change of -5.65 percentage points over the last eight quarters.
- The best year-over-year quarter for Gross Margin over five years was fiscal Q3 2022 (a gain of 55.78 percentage points); the worst was fiscal Q1 2022 (a drop of 13.06 percentage points).
- Per Business Quant data, AYTU's Gross Margin in the three fiscal quarters before Q4 2026 was 61.23% (Q3 2026), 63.46% (Q2 2026) and 66.14% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 75.71% |
| 10 | Aytu Biopharma | 22.17 Mn | -93.50 Mn | 10.41 Mn | 64.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.63% |
| Mar 31, 2026 | 61.23% |
| Dec 31, 2025 | 63.46% |
| Sep 30, 2025 | 66.14% |
| Jun 30, 2025 | 67.75% |
| Mar 31, 2025 | 69.40% |
| Dec 31, 2024 | 66.49% |
| Sep 30, 2024 | 72.31% |
| Jun 30, 2024 | 75.73% |
| Mar 31, 2024 | 73.88% |
| Dec 31, 2023 | 77.89% |
| Sep 30, 2023 | 73.18% |
| Jun 30, 2023 | 60.41% |
| Mar 31, 2023 | 56.06% |
| Dec 31, 2022 | 65.81% |
| Sep 30, 2022 | 65.20% |
| Jun 30, 2022 | 54.07% |
| Mar 31, 2022 | 52.42% |
| Dec 31, 2021 | 53.18% |
| Sep 30, 2021 | 56.88% |
API Access
Aytu Biopharma Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();